Maynard, MA, United States of America

Paul A Konowicz


 

 

Average Co-Inventor Count = 10.3

ph-index = 5

Forward Citations = 68(Granted Patents)


Location History:

  • Arlington, MA (US) (2013)
  • Maynard, MA (US) (2014 - 2022)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Paul A. Konowicz

Introduction

Paul A. Konowicz is a notable inventor based in Maynard, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of oligosaccharide-protein conjugates. With a total of 6 patents to his name, his work has implications for pharmaceutical compositions and treatments for lysosomal storage disorders.

Latest Patents

Among his latest patents, Konowicz has developed innovative oligosaccharide-protein conjugates. These conjugates comprise a protein and an oligosaccharide of specific formulae. Additionally, he has provided pharmaceutical compositions that include these conjugates. His methods focus on treating lysosomal storage disorders in mammals through the administration of oligosaccharide-glycoprotein conjugates.

Career Highlights

Konowicz is currently associated with Genzyme Corporation, a leader in biotechnology. His work at Genzyme has allowed him to explore and expand the applications of his inventions in the medical field. His dedication to research and development has positioned him as a key figure in his area of expertise.

Collaborations

Throughout his career, Konowicz has collaborated with talented individuals such as Luis Z. Avila and Clark Qun Pan. These collaborations have fostered an environment of innovation and have contributed to the advancement of their shared goals in biotechnology.

Conclusion

Paul A. Konowicz's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and pharmaceutical compositions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…